Firstred Capital

Firstred Capital is a private equity firm based in Beijing, China, founded in 2019. The firm focuses on growth and buyout investments primarily in the healthcare sector, as well as in consumer products and services. By targeting these industries, Firstred Capital aims to capitalize on emerging opportunities and foster the development of companies that have significant growth potential within the Chinese market.

Daniel Zhang

Managing Partner

9 past transactions

SECTREND

Seed Round in 2024
SECTREND specializes in addressing security and compliance challenges within the software supply chain. The company develops software composition analysis (SCA) tools that utilize advanced scanning detection technology and matching algorithms. These tools are designed to enhance the security compliance of open source software, enabling customers to better safeguard their networks. By providing governance services for open source security compliance, SECTREND aims to help organizations improve their overall security posture and effectively manage potential vulnerabilities in their software supply chains.

Lingxin Digital Technology

Series B in 2023
Lingxin Digital Technology is an emerging data security company facing the era of zero trust.

SECTREND

Seed Round in 2022
SECTREND specializes in addressing security and compliance challenges within the software supply chain. The company develops software composition analysis (SCA) tools that utilize advanced scanning detection technology and matching algorithms. These tools are designed to enhance the security compliance of open source software, enabling customers to better safeguard their networks. By providing governance services for open source security compliance, SECTREND aims to help organizations improve their overall security posture and effectively manage potential vulnerabilities in their software supply chains.

Bishi Technology

Series C in 2022
Bishi Technology is a tech enterprise in the field of intelligent operation and maintenance, Biztech has always been committed to providing enterprise users with easy-to-use and stable intelligent operation and maintenance products. Biz intelligent operation and maintenance platform is based on machine learning algorithms, helping large enterprise data centers to find faults in advance, locate fault ranges, predict trends in massive monitoring data, reduce mean time to repair (MTTR) and prolong system trouble-free running time (MTBF) , improve system availability and operation and maintenance efficiency.

Worktile Technology

Series C in 2022
Worktile Technology, established in 2013, is a Chinese software company headquartered in Beijing, with offices in Shanghai, Shenzhen, and Xi'an. It specializes in a web and mobile-based project management tool, designed to enhance team collaboration and productivity among developers and professionals. The platform facilitates task management, communication, and document sharing, aiming to streamline work processes and improve overall efficiency.

EXE

Venture Round in 2021
EXE offers enterprise online learning platforms, knowledge ecological operation platforms, and human capital operations to its users based on leading technologies such as big data and cloud computing. EXE's solutions are intended to boost the performance of Chinese businesses, institutions, and government agencies.

Allorion Therapeutics

Series A in 2021
Allorion Therapeutics is a small molecule therapeutic development company dedicated to creating innovative treatments for cancer and autoimmune diseases. With operational facilities in Natick, Massachusetts, and Guangzhou, China, Allorion specializes in developing mutant selective and isoform-specific drugs through unconventional methods targeting established disease pathways. This approach aims to enhance the efficacy of treatments and reduce the likelihood of resistance in patients, contributing to improved therapeutic outcomes.

Singleron Biotechnologies

Series B in 2021
Singleron Biotechnologies Ltd. is a molecular diagnostic company specializing in single cell sequencing solutions. Founded in 2018 and based in Nanjing, China, with additional offices and laboratories in Suzhou, the United States, and Germany, the firm develops a range of innovative products, including the Singleron Matrix automated instrument for high-density microwell processing and GEXSCOPE single cell RNA sequencing kits. The company also offers a microfluidic chip for cell partitioning, magnetic beads for cell barcoding, and tools for data analysis such as CeleScope and SynEcoSys, which facilitate the interpretation of single cell sequencing data. Singleron provides services in single cell RNA sequencing, single nucleus RNA sequencing, and bioinformatics analysis, aiming to advance clinical diagnosis, drug development, and health management. The company collaborates with research institutes, hospitals, and pharmaceutical firms primarily in China and the United States, leveraging its exclusive IP license from Yale University to enhance its innovative capabilities in single cell analysis.

Edge Medical Robotics

Series C in 2021
Edge Medical Robotics, Inc. is a company that specializes in designing and developing advanced surgical equipment. Founded on May 4, 2017, and based in Longgang, Shenzhen, China, the company is dedicated to researching and promoting cutting-edge medical technology. Its mission focuses on enhancing surgical safety and treatment efficacy, aiming to elevate the overall standards of healthcare. Through a commitment to excellence and precision in product development, Edge Medical Robotics strives to contribute positively to the improvement of social health outcomes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.